纳米颗粒的辐射保护效应:一个迷你回顾
Rasool Azmoonfar1, Masoud Moslehi1, Daryoush Shahbazi-Gahrouei1
1Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
IET nanobiotechnology
|June 12, 2024
概括
纳米颗粒显示出作为辐射保护剂的承诺,提供抗氧化和抗炎功效. 这些纳米粒子有效地保护器官免受辐射损伤,没有显著的副作用,表明治疗潜力.
科学领域:
- 纳米技术 纳米技术
- 辐射保护 辐射保护
- 生物医学科学 生物医学科学
背景情况:
- 电离辐射在医疗程序中存在风险.
- 开发有效的辐射保护剂至关重要.
- 纳米粒子 (SeNPs) 正在研究治疗应用.
研究的目的:
- 系统地审查纳米颗粒的辐射保护作用.
- 评估SeNP对电离辐射损伤的有效性和安全性.
- 探索SeNP的潜在治疗应用.
主要方法:
- 在遵守PRISMA指南的基础上进行系统审查.
- 在主要的科学数据库 (PubMed,Scopus,Web of Science,Science Direct) 中进行全面的文献搜索.
- 在对413篇初始文章进行严格选后,包括了10项相关研究.
主要成果:
- 纳米颗粒具有显著的抗炎和抗氧化特性.
- SeNPs对脏,肝脏和丸产生保护作用,防止辐射引起的损伤.
- 证据支持有效的辐射保护,没有观察到显著的不良影响.
结论:
- 纳米粒子具有作为有效辐射保护剂的潜力.
- SeNP可以减轻暴露于电离辐射的不良影响.
- 研究结果表明,SeNPs在医学成像和放射治疗中具有治疗应用.
更多相关视频
09:23Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
9.8K
06:00Biological Samples Preparation for Speciation at Cryogenic Temperature using High-Resolution X-Ray Absorption Spectroscopy
Published on: May 27, 2022
2.6K
相关概念视频
02:49Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K